Solid Biosciences Inc. SEC filings SLDB
Solid Biosciences Inc. has 737 filings in SEC EDGAR's recent list, going back to Aug 4, 2017. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 10, 2026 | Apr 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 12, 2026 | Mar 11, 2026 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Other events
|
Mar 6, 2026 | Mar 6, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Nov 3, 2025 | Nov 3, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 13, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Other events
|
May 15, 2025 | May 15, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 18, 2025 | Feb 18, 2025 |
| 8-K |
Current report
Other events
|
Feb 18, 2025 | Feb 18, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 18, 2025 | Feb 18, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 11, 2024 | Jun 7, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure, Other events
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 15, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 9, 2023 | Jun 6, 2023 |
| 8-K |
Current report
Officer or director change
|
May 22, 2023 | May 22, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 20, 2023 | Mar 19, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2023 | Mar 13, 2023 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure, Other events
|
Jan 9, 2023 | Jan 6, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Exit or restructuring costs, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Dec 5, 2022 | Nov 30, 2022 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Dec 1, 2022 | Dec 1, 2022 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Oct 27, 2022 | Oct 27, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 30, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure, Other events
|
Sep 30, 2022 | Sep 29, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2022 | Jun 7, 2022 |
| 8-K |
Current report
Listing notice
|
Jun 6, 2022 | May 31, 2022 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Apr 27, 2022 | Apr 22, 2022 |
| 8-K | Current report | Apr 4, 2022 | Mar 30, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Other events
|
Sep 29, 2021 | Sep 29, 2021 |
| 8-K/A |
Amended current report
Other events
|
Sep 27, 2021 | Sep 23, 2021 |
| 8-K |
Current report
Other events
|
Sep 23, 2021 | Sep 23, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 16, 2021 | Aug 16, 2021 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 17, 2021 | Jun 16, 2021 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 16, 2021 | Jun 15, 2021 |
| 8-K |
Current report
Results of operations
|
May 14, 2021 | May 14, 2021 |
| 8-K/A |
Amended current report
Officer or director change
|
Apr 16, 2021 | Mar 2, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 19, 2021 | Mar 18, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 15, 2021 | Mar 15, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 5, 2021 | Mar 2, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 11, 2021 | Jan 11, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Dec 11, 2020 | Dec 10, 2020 |
| 8-K |
Current report
Officer or director change
|
Nov 20, 2020 | Nov 18, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Other events
|
Oct 26, 2020 | Oct 23, 2020 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Other events
|
Oct 23, 2020 | Oct 22, 2020 |
| 8-K |
Current report
Other events
|
Oct 1, 2020 | Oct 1, 2020 |
| 8-K |
Current report
Other events
|
Jul 27, 2020 | Jul 24, 2020 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 18, 2020 | Jun 16, 2020 |
| 8-K |
Current report
Other events
|
May 7, 2020 | May 7, 2020 |
| 8-K |
Current report
Officer or director change, Other events
|
Apr 16, 2020 | Apr 15, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2020 | Mar 12, 2020 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change, Other events
|
Jan 9, 2020 | Jan 7, 2020 |
| 8-K |
Current report
Other events
|
Dec 18, 2019 | Dec 18, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2019 | Aug 14, 2019 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 26, 2019 | Jul 25, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2019 | Jun 13, 2019 |
| 8-K |
Current report
Results of operations
|
May 13, 2019 | May 13, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2019 | Mar 13, 2019 |
| 8-K |
Current report
Officer or director change
|
Jan 28, 2019 | Jan 25, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2019 | Jan 7, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2018 | Nov 13, 2018 |
| 8-K |
Current report
Officer or director change
|
Sep 13, 2018 | Sep 12, 2018 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2018 | Aug 10, 2018 |
| 8-K |
Current report
Officer or director change
|
Jun 26, 2018 | Jun 22, 2018 |
| 8-K |
Current report
Results of operations
|
May 10, 2018 | May 10, 2018 |
| 8-K |
Current report
Results of operations
|
Mar 29, 2018 | Mar 29, 2018 |
Showing 68 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- SLDB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Charlestown, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1707502
- Former names
- Solid Biosciences, LLC (until Jan 25, 2018)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.